Vaxxinity Inc (VAXX)
0.05
-0.04
(-44.44%)
USD |
OTCM |
Sep 18, 15:14
Vaxxinity Total Liabilities (Quarterly): 30.90M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.90M |
| September 30, 2023 | 33.77M |
| June 30, 2023 | 36.36M |
| March 31, 2023 | 39.40M |
| December 31, 2022 | 44.22M |
| September 30, 2022 | 42.70M |
| Date | Value |
|---|---|
| June 30, 2022 | 39.66M |
| March 31, 2022 | 34.87M |
| December 31, 2021 | 38.05M |
| September 30, 2021 | 292.28M |
| June 30, 2021 | 283.71M |
| December 31, 2020 | 137.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.90M
Minimum
Dec 2023
292.28M
Maximum
Sep 2021
87.79M
Average
39.53M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.31M |
| Shareholders Equity (Quarterly) | 13.41M |